STOCK TITAN

Emily Leproust sells multiple TWST shares (NASDAQ: TWST)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Twist Bioscience (issuer) reported insider dispositions by Emily M. Leproust of Common stock on multiple dates. Transactions listed: 5,001 shares on 02/03/2026, 7,205 shares on 02/23/2026, 2,423 shares on 03/06/2026, 1,742 shares on 03/20/2026, and 1,610 shares on 04/21/2026. The filing also shows 8,061 shares described under "Securities To Be Sold" with an option grant date of 09/29/2017.

Positive

  • None.

Negative

  • None.
Sale on 02/03/2026 5,001 shares Disposition by Emily M. Leproust
Sale on 02/23/2026 7,205 shares Disposition by Emily M. Leproust
Sale on 03/06/2026 2,423 shares Disposition by Emily M. Leproust
Sale on 03/20/2026 1,742 shares Disposition by Emily M. Leproust
Sale on 04/21/2026 1,610 shares Disposition by Emily M. Leproust
Securities to be sold entry 8,061 shares Listed 04/22/2026 with option grant date 09/29/2017
Form 144 regulatory
"Filer Information | 144: Filer Information"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Securities To Be Sold regulatory
"Common | 04/22/2026 | Option Granted - 09/29/2017"
Disposition for cash financial
"04/22/2026 | Cash"
Option Granted financial
"Option Granted - 09/29/2017"

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What did the Form 144 for TWST disclose?

It discloses multiple insider sales by Emily M. Leproust. The filing lists five open‑market dispositions dated 02/03/2026, 02/23/2026, 03/06/2026, 03/20/2026, and 04/21/2026 with the share counts and cash amounts shown per sale.

How many shares did Emily M. Leproust sell in each transaction?

Individual sales were 5,001; 7,205; 2,423; 1,742; and 1,610 shares. Each sale is paired with a cash amount in the filing for the corresponding trade date as listed in the record.

What is the 8,061‑share entry shown in the filing?

The filing shows 8,061 shares under "Securities To Be Sold" dated 04/22/2026. That line references an option granted on 09/29/2017 and lists the method as cash; the entry appears separate from the earlier sales rows.

Does the Form 144 state who received the cash from the sales?

The filing lists the transactions as dispositions by the reporting person. The rows show cash proceeds per sale; the filing does not allocate proceeds beyond the seller entries shown in the excerpt.

Are these transactions reported as open‑market sales or another method?

The sales in the excerpt are shown with cash amounts, indicating dispositions for cash. The "Securities To Be Sold" line references an option and cash; specific distribution methods beyond that wording are not detailed in the excerpt.